Joseph J. Eron

机构：University of North Carolina at Chapel Hill

发表论文 56 篇 · 总被引 2861 次 · h-index 25

代表论文

• Renal safety of tenofovir alafenamide vs. tenofovir disoproxil fumarate (2019 · AIDS · 被引 162)
• Safety of teropavimab and zinlirvimab with lenacapavir once every 6 months for HIV treatment: a phase 1b, randomised, proof-of-concept study (2024 · The Lancet HIV · 被引 47)
• Week 96 results of a phase 3 trial of darunavir/cobicistat/emtricitabine/tenofovir alafenamide in treatment-naive HIV-1 patients (2019 · AIDS · 被引 37)
• Week 96 efficacy and safety results of the phase 3, randomized EMERALD trial to evaluate switching from boosted-protease inhibitors plus emtricitabine/tenofovir disoproxil fumarate regimens to the once daily, single-tablet regimen of darunavir/cobicistat/emtricitabine/tenofovir alafenamide (D/C/F/TAF) in treatment-experienced, virologically-suppressed adults living with HIV-1 (2019 · Antiviral Research · 被引 36)
• Week 48 Resistance Analyses of the Once-Daily, Single-Tablet Regimen Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) in Adults Living with HIV-1 from the Phase III Randomized AMBER and EMERALD Trials (2019 · AIDS Research and Human Retroviruses · 被引 14)
• Darunavir/cobicistat/emtricitabine/tenofovir alafenamide in treatment-experienced, virologically suppressed patients with HIV-1: subgroup analyses of the phase 3 EMERALD study (2019 · AIDS Research and Therapy · 被引 11)